Avilar Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Avilar Therapeutics is a biotechnology company based in Waltham, Massachusetts, focused on extracellular protein degradation. It develops ATACs (ASGPR Targeting Chimeras), a therapeutic modality that moves disease-causing extracellular proteins from circulation to the endolysosome for degradation. The ATAC platform combines high-affinity ASGPR ligands with modeling of biophysics and pharmacokinetic/pharmacodynamic behavior to enable modular design across the extracellular proteome. In 2023, the company expanded its board with Paulina Hill, and it was established in 2021, situating its operations in the greater Boston area.